Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board ...

KANSAS CITY, Kan., April 30, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and

Related Keywords

Kansas ,United States ,Kansas City ,Thomas Dalton ,Shanej Schaffer ,Peterj Werth ,Matt Kreps ,Benzinga Youtube ,Securities Exchange ,Exchange Commission ,Chemwerth Inc ,Cingulate Inc ,Darrow Associates ,Nasdaq ,Precision Timed Release ,Cingulate Chairman ,Benzinga All Access ,Friday May ,Cingulate Investor ,Board Member Peter ,Benzinga All Live ,Looking Statements ,Securities Act ,Securities Exchange Act ,Annual Report ,Public Relations ,